Clinical Trials Directory

Trials / Unknown

UnknownNCT03864809

• Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between Them

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Comparison between sleep disturbance in atopy and psoriasis and control

Detailed description

Sleep is essential for daytime functioning and health and important for both psychological and physiological wellbeing . A growing body of research indicates that chronic sleep disturbance is associated with impaired quality of life (QoL) and a risk factor for poorer health, for example depression cardiovascular disease, hypertension 1 and diabetes. insomnia, the most common sleep disorder, is a clinical condition defined as difficulties falling asleep and/or maintaining sleep and/or poor sleep quality despite adequate opportunity for sleep resulting in significant daytime impairment. The development of insomnia in healthy populations has a bi-directional relationship with psychological factors such as anxiety, depressive symptoms and stress, and may in clinical populations also be associated with physical symptoms, such as pain. the physical symptoms in psoriasis, such as itch, one would expect a higher prevalence of sleep disturbance in this patient group. On the other hand Sleep disturbance is common also in patients with atopic dermatitis (AD). Patients with AD often have sleep disturbances due to pruritus.

Conditions

Interventions

TypeNameDescription
BEHAVIORALsleep disturbancewe observe sleep disturbance among patients with psoriasis and atopic dermatitis and control group

Timeline

Start date
2019-06-01
Primary completion
2020-07-01
Completion
2020-08-01
First posted
2019-03-06
Last updated
2019-03-07

Source: ClinicalTrials.gov record NCT03864809. Inclusion in this directory is not an endorsement.